NMPA Approval

Levetiracetam Concentrated Solution for Injection

Approval Number

国药准字H20213985

Company成都利尔药业有限公司

Registration Date

December 31, 2021

Drug Information

Generic Name

左乙拉西坦注射用浓溶液

Dosage Form

注射剂

Strength

5ml:500mg

Drug Type

化学药品

Registration Date

December 31, 2021

Company Information

Applicant Company

Company Name成都利尔药业有限公司

Company Address

四川省成都市都江堰市四川都江堰经济开发区堰华路631号

Manufacturing Company

Company Name成都利尔药业有限公司

Company Address

都江堰市蒲阳镇堰华路631号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.